Dialysis world news


Study finds significantly higher rate of untreated kidney failure among older ... - EurekAlert (press release)
EurekAlert (press release)
"Studies of the association among age, kidney function, and clinical outcomes have reported that elderly patients are less likely to develop end-stage renal disease (ESRD) compared with younger patients and are more likely to die than to progress to

...

 
Research and Markets: Saudi Arabia Nephrology and Urology ... - Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7ptrvw/saudi_arabia_nephr) has announced the addition of GlobalData's new report "Saudi Arabia Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“Saudi Arabia Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

GlobalData's new report, Saudi Arabia Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters provides key market data on the Saudi Arabia Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Saudi Arabia Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned

- Fresenius Medical Care AG & Co. KGaA

- Gambro AB

- Baxter International Inc.

- Dornier MedTech GmbH

- B. Braun Melsungen AG

- Siemens Healthcare

- NIPRO CORPORATION

- Svenska Cellulosa Aktiebolaget SCA

- HARTMANN GROUP

- Medline Industries, Inc.

- Kimberly-Clark Corporation

- STORZ MEDICAL AG

- First Quality Enterprises, Inc.

- Covidien plc

- C. R. Bard, Inc.

For more information visit http://www.researchandmarkets.com/research/7ptrvw/saudi_arabia_nephr

Source: GlobalData

...

 
Alarming increase in hypertension in US children - TheHeart.Org
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

image Get 30 days of free access to heartwire news

...

 
Life on MARS: Emory Offers Lifesaving Liver Dialysis System for ... - Houston Chronicle

Emory one of only five health centers nationwide to offer Molecular Adsorbents Recirculating System (MARS), a liver dialysis system approved by the U.S. Food and Drug Administration (FDA) to treat select patients with acute liver failure due to drugs or toxins.

Atlanta, GA (PRWEB) June 19, 2012

For many patients with acute liver failure, the only hope for treatment is a liver transplant. With transplant, waiting for an organ to become available can take a long time – time the patient does not have.

Emory is only one of five centers in the U.S. and the only one in the Southeast to offer the Molecular Adsorbents Recirculating System (MARS), a liver dialysis system recently approved by the U.S. Food and Drug Administration (FDA) to treat select patients with acute liver failure due to drugs or toxins. MARS can be used either as a bridge to transplant or spontaneous recovery, and highlights Emory’s institutional commitment to providing comprehensive, state-of-the-art liver critical care.

Says transplant hepatologist and intensivist Ram Subramanian, assistant professor at Emory University School of Medicine, “We have long had kidney dialysis to stabilize patients in renal failure, but until now, we have not had a corresponding method of treatment for patients in acute liver failure. MARS is a potential game changer for patients who either don’t qualify for transplant or who don’t have the time that is critical to wait for a liver transplant.”

Acute liver failure does not allow patients to clear certain toxins from their systems. The MARS system works by drawing blood from patients and cleansing it with a solution containing albumin. Albumin is produced by healthy livers and binds to certain medications and other bodily substances to transports them throughout the body while protecting the body from their toxic effects. This cleansed blood is returned to the patient’s circulatory system to attract more toxins.

MARS is the only FDA approved treatment of acute liver failure, but is currently under clinical trial investigation to treat forms of chronic liver illness.

“Several studies in Europe have demonstrated that MARS is effective in treating chronic liver failure as well,” says Subramanian. “My hope is that it becomes another tool for us in offering hope to patients who are dealing with all kinds of liver failure.”

Learn more about the MARS liver dialysis system in a video interview with Ram Subramanian, MD.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/6/prweb9615939.htm

...

 
Giving kids a better life - Northland Independent Community

ESTHER LAUAKI Last updated 05:00 20/06/2012 Kidney Kids ESTHER LAUAKI

HEALTHY CONTRIBUTION: Paediatric nephrologist Dr William Wong from Starship children's hospital with one of two haemodialysis machines that will help treat kids with kidney disease.

There are only four nephrologists in New Zealand and Dr William Wong is one of them.

It is likely you will have met him if yours is one of the 1200 families that has a child born with abnormal kidneys or congenital kidney disease.

Dr Wong is the director of paediatric nephrology at Starship children's hospital and has served in the field for 18 years.

He was the second kidney specialist in this country after training under New Zealand's first nephrologist Dr Max Morris 22 years ago.

"I enjoy it because I like a challenge," he says. "You see the patients and you get them well again. They run around and they are well. It's very gratifying to see. Within a few weeks of their transplant, they are living almost normal lives. It's an area which is often changing with a lot of new development which keeps things exciting."

Dr Wong has been seeing some of his patients since they were babies and will be with them throughout their teen years too.

"We start off with dialysis treatment. That is a big part of our work. Children are often very sick at the beginning and we've got to get them back to a state where they are able to lead healthier, better lives. That is very resource intensive and we need machines for that ... patients can't survive without dialysis."

Children on peritoneal dialysis can be treated at home but haemodialysis requires kids to visit the hospital and is reserved for serious cases.

A haemodialysis machine cleans the patient's blood by running it through an artificial kidney before returning it to the body.

That means sitting still for four-hour sessions, three or four times a week and it costs roughly $100,000 a year to help one person, Dr Wong says.

Starship has two haemodialysis machines and four children on haemodialysis at present.

The Mad Butcher and Suburban Newspapers Community Trust and Kidney Kids, is fundraising to buy four haemodialysis machines for the first-ever national dedicated Paediatric Haemodialysis Unit at Starship.

It has called the exercise Project Kidney and needs $132,000 to achieve its goal and help make a difference for the many youngsters affected from all over the country.

Any extra proceeds will go towards the unit and additional equipment.

"Just a dollar from each of our readers would pay for these machines many times over," trust chairman and Suburban Newspapers general manager David Penny says.

"This is one of those causes that we should all support in whatever way we can. Kidney disease is widespread and could affect any one of us or our families," he says.

Dr Wong says diabetes, diet and other lifestyle choices are often factors contributing to the problem among adults.

But many children are the victims of genetics. "They're born with it and the causes are evident in children from birth right through to 16 or 17 years old," he says.

HOW YOU CAN HELP:
Donations can be made at the Western Leader, 2 Waipareira Ave, Henderson, or posted to Project Kidney, Mad Butcher and Suburban Newspapers Community Trust, PO Box 92815, Penrose, Auckland. You can also bank your contribution direct into the Project Kidney account 03 0243 0268896 00 at any branch of Westpac.

- © Fairfax NZ News

Sponsored links

...

 
<< Start < Prev 301 302 303 304 305 306 307 308 309 310 Next > End >>

Page 305 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.